Use of liposomal amphotericin B in the treatment of disseminated coccidioidomycosis.
Disseminated fungal infection is an important cause of morbidity and mortality, especially in immunocompromised hosts. Amphotericin B is an important part of the therapy and treatment of invasive and life-threatening mycoses. We present a case of disseminated coccidioidomycosis in a patient who was successfully treated with liposomal amphotericin B (AmBisome) on steroid therapy. It appears that liposomal amphotericin B may offer an alternative and safe option in the treatment of coccidioidomycosis when conventional amphotericin B cannot be used.
Antony
Suresh
S
U.S. Oncology, El Paso Cancer Treatment Center, 7848 Gateway East, El Paso, TX 79915, USA. Santony999@aol.com
Dominguez
Delfina C
DC
Sotelo
Elsa
E
D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage* / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003047:Coccidioidomycosis / Q000188:drug therapy*; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D008081:Liposomes; D008297:Male
D000935:Antifungal Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B; D015725:Fluconazole